Global Gastrointestinal Stromal Tumor (GIST) Drug Supply, Demand and Key Producers, 2023-2029

Page: 121

Published Date: 07 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

This report studies the global Gastrointestinal Stromal Tumor (GIST) Drug production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Gastrointestinal Stromal Tumor (GIST) Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gastrointestinal Stromal Tumor (GIST) Drug that contribute to its increasing demand across many markets.

The global Gastrointestinal Stromal Tumor (GIST) Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global Gastrointestinal Stromal Tumor (GIST) Drug total production and demand, 2018-2029, (K Pcs)
Global Gastrointestinal Stromal Tumor (GIST) Drug total production value, 2018-2029, (USD Million)
Global Gastrointestinal Stromal Tumor (GIST) Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Pcs)
Global Gastrointestinal Stromal Tumor (GIST) Drug consumption by region & country, CAGR, 2018-2029 & (K Pcs)
U.S. VS China: Gastrointestinal Stromal Tumor (GIST) Drug domestic production, consumption, key domestic manufacturers and share
Global Gastrointestinal Stromal Tumor (GIST) Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Pcs)
Global Gastrointestinal Stromal Tumor (GIST) Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Pcs)
Global Gastrointestinal Stromal Tumor (GIST) Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Pcs)
This reports profiles key players in the global Gastrointestinal Stromal Tumor (GIST) Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ariad Pharmaceuticals, Inc., Arog Pharmaceuticals, Inc., Array BioPharma Inc., Astex Pharmaceuticals, Inc., Blueprint Medicines Corporation, Boston Biomedical, Inc., Calithera Biosciences, Inc., Chipscreen Biosciences Ltd and Deciphera Pharmaceuticals, LLC, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gastrointestinal Stromal Tumor (GIST) Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Pcs) and average price (USD/Pcs) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Gastrointestinal Stromal Tumor (GIST) Drug Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Gastrointestinal Stromal Tumor (GIST) Drug Market, Segmentation by Type
    Amcasertib
    Anagrelide hydrochloride CR
    APG-1351
    Binimetinib
    Others

Global Gastrointestinal Stromal Tumor (GIST) Drug Market, Segmentation by Application
    Clinic
    Hospital
    Others

Companies Profiled:
    Ariad Pharmaceuticals, Inc.
    Arog Pharmaceuticals, Inc.
    Array BioPharma Inc.
    Astex Pharmaceuticals, Inc.
    Blueprint Medicines Corporation
    Boston Biomedical, Inc.
    Calithera Biosciences, Inc.
    Chipscreen Biosciences Ltd
    Deciphera Pharmaceuticals, LLC
    F. Hoffmann-La Roche Ltd.
    Horizon Pharma Plc
    Immunicum AB
    Jiangsu Hengrui Medicine Co., Ltd.
    Kolltan Pharmaceuticals, Inc.
    Natco Pharma Limited
    Nerviano Medical Sciences S.r.l.
    Novartis AG
    Omeros Corporation

Key Questions Answered
1. How big is the global Gastrointestinal Stromal Tumor (GIST) Drug market?
2. What is the demand of the global Gastrointestinal Stromal Tumor (GIST) Drug market?
3. What is the year over year growth of the global Gastrointestinal Stromal Tumor (GIST) Drug market?
4. What is the production and production value of the global Gastrointestinal Stromal Tumor (GIST) Drug market?
5. Who are the key producers in the global Gastrointestinal Stromal Tumor (GIST) Drug market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Gastrointestinal Stromal Tumor (GIST) Drug Introduction
    1.2 World Gastrointestinal Stromal Tumor (GIST) Drug Supply & Forecast
        1.2.1 World Gastrointestinal Stromal Tumor (GIST) Drug Production Value (2018 & 2022 & 2029)
        1.2.2 World Gastrointestinal Stromal Tumor (GIST) Drug Production (2018-2029)
        1.2.3 World Gastrointestinal Stromal Tumor (GIST) Drug Pricing Trends (2018-2029)
    1.3 World Gastrointestinal Stromal Tumor (GIST) Drug Production by Region (Based on Production Site)
        1.3.1 World Gastrointestinal Stromal Tumor (GIST) Drug Production Value by Region (2018-2029)
        1.3.2 World Gastrointestinal Stromal Tumor (GIST) Drug Production by Region (2018-2029)
        1.3.3 World Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Region (2018-2029)
        1.3.4 North America Gastrointestinal Stromal Tumor (GIST) Drug Production (2018-2029)
        1.3.5 Europe Gastrointestinal Stromal Tumor (GIST) Drug Production (2018-2029)
        1.3.6 China Gastrointestinal Stromal Tumor (GIST) Drug Production (2018-2029)
        1.3.7 Japan Gastrointestinal Stromal Tumor (GIST) Drug Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Gastrointestinal Stromal Tumor (GIST) Drug Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Gastrointestinal Stromal Tumor (GIST) Drug Demand (2018-2029)
    2.2 World Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Region
        2.2.1 World Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Region (2018-2023)
        2.2.2 World Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast by Region (2024-2029)
    2.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2018-2029)
    2.4 China Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2018-2029)
    2.5 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2018-2029)
    2.6 Japan Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2018-2029)
    2.7 South Korea Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2018-2029)
    2.8 ASEAN Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2018-2029)
    2.9 India Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2018-2029)

3 World Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers Competitive Analysis
    3.1 World Gastrointestinal Stromal Tumor (GIST) Drug Production Value by Manufacturer (2018-2023)
    3.2 World Gastrointestinal Stromal Tumor (GIST) Drug Production by Manufacturer (2018-2023)
    3.3 World Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Manufacturer (2018-2023)
    3.4 Gastrointestinal Stromal Tumor (GIST) Drug Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Gastrointestinal Stromal Tumor (GIST) Drug in 2022
        3.5.3 Global Concentration Ratios (CR8) for Gastrointestinal Stromal Tumor (GIST) Drug in 2022
    3.6 Gastrointestinal Stromal Tumor (GIST) Drug Market: Overall Company Footprint Analysis
        3.6.1 Gastrointestinal Stromal Tumor (GIST) Drug Market: Region Footprint
        3.6.2 Gastrointestinal Stromal Tumor (GIST) Drug Market: Company Product Type Footprint
        3.6.3 Gastrointestinal Stromal Tumor (GIST) Drug Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Gastrointestinal Stromal Tumor (GIST) Drug Production Value Comparison
        4.1.1 United States VS China: Gastrointestinal Stromal Tumor (GIST) Drug Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Gastrointestinal Stromal Tumor (GIST) Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Gastrointestinal Stromal Tumor (GIST) Drug Production Comparison
        4.2.1 United States VS China: Gastrointestinal Stromal Tumor (GIST) Drug Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Gastrointestinal Stromal Tumor (GIST) Drug Consumption Comparison
        4.3.1 United States VS China: Gastrointestinal Stromal Tumor (GIST) Drug Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production (2018-2023)
    4.5 China Based Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers and Market Share
        4.5.1 China Based Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production Value (2018-2023)
        4.5.3 China Based Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production (2018-2023)
    4.6 Rest of World Based Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production (2018-2023)

5 Market Analysis by Type
    5.1 World Gastrointestinal Stromal Tumor (GIST) Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Amcasertib
        5.2.2 Anagrelide hydrochloride CR
        5.2.3 APG-1351
        5.2.4 Binimetinib
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Gastrointestinal Stromal Tumor (GIST) Drug Production by Type (2018-2029)
        5.3.2 World Gastrointestinal Stromal Tumor (GIST) Drug Production Value by Type (2018-2029)
        5.3.3 World Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Gastrointestinal Stromal Tumor (GIST) Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Clinic
        6.2.2 Hospital
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Gastrointestinal Stromal Tumor (GIST) Drug Production by Application (2018-2029)
        6.3.2 World Gastrointestinal Stromal Tumor (GIST) Drug Production Value by Application (2018-2029)
        6.3.3 World Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Ariad Pharmaceuticals, Inc.
        7.1.1 Ariad Pharmaceuticals, Inc. Details
        7.1.2 Ariad Pharmaceuticals, Inc. Major Business
        7.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        7.1.4 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Ariad Pharmaceuticals, Inc. Recent Developments/Updates
        7.1.6 Ariad Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
    7.2 Arog Pharmaceuticals, Inc.
        7.2.1 Arog Pharmaceuticals, Inc. Details
        7.2.2 Arog Pharmaceuticals, Inc. Major Business
        7.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        7.2.4 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Arog Pharmaceuticals, Inc. Recent Developments/Updates
        7.2.6 Arog Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
    7.3 Array BioPharma Inc.
        7.3.1 Array BioPharma Inc. Details
        7.3.2 Array BioPharma Inc. Major Business
        7.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        7.3.4 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Array BioPharma Inc. Recent Developments/Updates
        7.3.6 Array BioPharma Inc. Competitive Strengths & Weaknesses
    7.4 Astex Pharmaceuticals, Inc.
        7.4.1 Astex Pharmaceuticals, Inc. Details
        7.4.2 Astex Pharmaceuticals, Inc. Major Business
        7.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        7.4.4 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Astex Pharmaceuticals, Inc. Recent Developments/Updates
        7.4.6 Astex Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
    7.5 Blueprint Medicines Corporation
        7.5.1 Blueprint Medicines Corporation Details
        7.5.2 Blueprint Medicines Corporation Major Business
        7.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        7.5.4 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Blueprint Medicines Corporation Recent Developments/Updates
        7.5.6 Blueprint Medicines Corporation Competitive Strengths & Weaknesses
    7.6 Boston Biomedical, Inc.
        7.6.1 Boston Biomedical, Inc. Details
        7.6.2 Boston Biomedical, Inc. Major Business
        7.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        7.6.4 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Boston Biomedical, Inc. Recent Developments/Updates
        7.6.6 Boston Biomedical, Inc. Competitive Strengths & Weaknesses
    7.7 Calithera Biosciences, Inc.
        7.7.1 Calithera Biosciences, Inc. Details
        7.7.2 Calithera Biosciences, Inc. Major Business
        7.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        7.7.4 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Calithera Biosciences, Inc. Recent Developments/Updates
        7.7.6 Calithera Biosciences, Inc. Competitive Strengths & Weaknesses
    7.8 Chipscreen Biosciences Ltd
        7.8.1 Chipscreen Biosciences Ltd Details
        7.8.2 Chipscreen Biosciences Ltd Major Business
        7.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        7.8.4 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Chipscreen Biosciences Ltd Recent Developments/Updates
        7.8.6 Chipscreen Biosciences Ltd Competitive Strengths & Weaknesses
    7.9 Deciphera Pharmaceuticals, LLC
        7.9.1 Deciphera Pharmaceuticals, LLC Details
        7.9.2 Deciphera Pharmaceuticals, LLC Major Business
        7.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        7.9.4 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Deciphera Pharmaceuticals, LLC Recent Developments/Updates
        7.9.6 Deciphera Pharmaceuticals, LLC Competitive Strengths & Weaknesses
    7.10 F. Hoffmann-La Roche Ltd.
        7.10.1 F. Hoffmann-La Roche Ltd. Details
        7.10.2 F. Hoffmann-La Roche Ltd. Major Business
        7.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        7.10.4 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
        7.10.6 F. Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
    7.11 Horizon Pharma Plc
        7.11.1 Horizon Pharma Plc Details
        7.11.2 Horizon Pharma Plc Major Business
        7.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        7.11.4 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Horizon Pharma Plc Recent Developments/Updates
        7.11.6 Horizon Pharma Plc Competitive Strengths & Weaknesses
    7.12 Immunicum AB
        7.12.1 Immunicum AB Details
        7.12.2 Immunicum AB Major Business
        7.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        7.12.4 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Immunicum AB Recent Developments/Updates
        7.12.6 Immunicum AB Competitive Strengths & Weaknesses
    7.13 Jiangsu Hengrui Medicine Co., Ltd.
        7.13.1 Jiangsu Hengrui Medicine Co., Ltd. Details
        7.13.2 Jiangsu Hengrui Medicine Co., Ltd. Major Business
        7.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        7.13.4 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments/Updates
        7.13.6 Jiangsu Hengrui Medicine Co., Ltd. Competitive Strengths & Weaknesses
    7.14 Kolltan Pharmaceuticals, Inc.
        7.14.1 Kolltan Pharmaceuticals, Inc. Details
        7.14.2 Kolltan Pharmaceuticals, Inc. Major Business
        7.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        7.14.4 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 Kolltan Pharmaceuticals, Inc. Recent Developments/Updates
        7.14.6 Kolltan Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
    7.15 Natco Pharma Limited
        7.15.1 Natco Pharma Limited Details
        7.15.2 Natco Pharma Limited Major Business
        7.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        7.15.4 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.15.5 Natco Pharma Limited Recent Developments/Updates
        7.15.6 Natco Pharma Limited Competitive Strengths & Weaknesses
    7.16 Nerviano Medical Sciences S.r.l.
        7.16.1 Nerviano Medical Sciences S.r.l. Details
        7.16.2 Nerviano Medical Sciences S.r.l. Major Business
        7.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        7.16.4 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.16.5 Nerviano Medical Sciences S.r.l. Recent Developments/Updates
        7.16.6 Nerviano Medical Sciences S.r.l. Competitive Strengths & Weaknesses
    7.17 Novartis AG
        7.17.1 Novartis AG Details
        7.17.2 Novartis AG Major Business
        7.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        7.17.4 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.17.5 Novartis AG Recent Developments/Updates
        7.17.6 Novartis AG Competitive Strengths & Weaknesses
    7.18 Omeros Corporation
        7.18.1 Omeros Corporation Details
        7.18.2 Omeros Corporation Major Business
        7.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        7.18.4 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.18.5 Omeros Corporation Recent Developments/Updates
        7.18.6 Omeros Corporation Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Chain
    8.2 Gastrointestinal Stromal Tumor (GIST) Drug Upstream Analysis
        8.2.1 Gastrointestinal Stromal Tumor (GIST) Drug Core Raw Materials
        8.2.2 Main Manufacturers of Gastrointestinal Stromal Tumor (GIST) Drug Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Gastrointestinal Stromal Tumor (GIST) Drug Production Mode
    8.6 Gastrointestinal Stromal Tumor (GIST) Drug Procurement Model
    8.7 Gastrointestinal Stromal Tumor (GIST) Drug Industry Sales Model and Sales Channels
        8.7.1 Gastrointestinal Stromal Tumor (GIST) Drug Sales Model
        8.7.2 Gastrointestinal Stromal Tumor (GIST) Drug Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Gastrointestinal Stromal Tumor (GIST) Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Gastrointestinal Stromal Tumor (GIST) Drug Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Gastrointestinal Stromal Tumor (GIST) Drug Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Gastrointestinal Stromal Tumor (GIST) Drug Production Value Market Share by Region (2018-2023)
    Table 5. World Gastrointestinal Stromal Tumor (GIST) Drug Production Value Market Share by Region (2024-2029)
    Table 6. World Gastrointestinal Stromal Tumor (GIST) Drug Production by Region (2018-2023) & (K Pcs)
    Table 7. World Gastrointestinal Stromal Tumor (GIST) Drug Production by Region (2024-2029) & (K Pcs)
    Table 8. World Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Region (2018-2023)
    Table 9. World Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Region (2024-2029)
    Table 10. World Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Region (2018-2023) & (USD/Pcs)
    Table 11. World Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Region (2024-2029) & (USD/Pcs)
    Table 12. Gastrointestinal Stromal Tumor (GIST) Drug Major Market Trends
    Table 13. World Gastrointestinal Stromal Tumor (GIST) Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Pcs)
    Table 14. World Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Region (2018-2023) & (K Pcs)
    Table 15. World Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast by Region (2024-2029) & (K Pcs)
    Table 16. World Gastrointestinal Stromal Tumor (GIST) Drug Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Gastrointestinal Stromal Tumor (GIST) Drug Producers in 2022
    Table 18. World Gastrointestinal Stromal Tumor (GIST) Drug Production by Manufacturer (2018-2023) & (K Pcs)
    Table 19. Production Market Share of Key Gastrointestinal Stromal Tumor (GIST) Drug Producers in 2022
    Table 20. World Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Manufacturer (2018-2023) & (USD/Pcs)
    Table 21. Global Gastrointestinal Stromal Tumor (GIST) Drug Company Evaluation Quadrant
    Table 22. World Gastrointestinal Stromal Tumor (GIST) Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Gastrointestinal Stromal Tumor (GIST) Drug Production Site of Key Manufacturer
    Table 24. Gastrointestinal Stromal Tumor (GIST) Drug Market: Company Product Type Footprint
    Table 25. Gastrointestinal Stromal Tumor (GIST) Drug Market: Company Product Application Footprint
    Table 26. Gastrointestinal Stromal Tumor (GIST) Drug Competitive Factors
    Table 27. Gastrointestinal Stromal Tumor (GIST) Drug New Entrant and Capacity Expansion Plans
    Table 28. Gastrointestinal Stromal Tumor (GIST) Drug Mergers & Acquisitions Activity
    Table 29. United States VS China Gastrointestinal Stromal Tumor (GIST) Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Gastrointestinal Stromal Tumor (GIST) Drug Production Comparison, (2018 & 2022 & 2029) & (K Pcs)
    Table 31. United States VS China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Pcs)
    Table 32. United States Based Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production (2018-2023) & (K Pcs)
    Table 36. United States Based Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2018-2023)
    Table 37. China Based Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production (2018-2023) & (K Pcs)
    Table 41. China Based Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2018-2023)
    Table 42. Rest of World Based Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production (2018-2023) & (K Pcs)
    Table 46. Rest of World Based Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2018-2023)
    Table 47. World Gastrointestinal Stromal Tumor (GIST) Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Gastrointestinal Stromal Tumor (GIST) Drug Production by Type (2018-2023) & (K Pcs)
    Table 49. World Gastrointestinal Stromal Tumor (GIST) Drug Production by Type (2024-2029) & (K Pcs)
    Table 50. World Gastrointestinal Stromal Tumor (GIST) Drug Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Gastrointestinal Stromal Tumor (GIST) Drug Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Type (2018-2023) & (USD/Pcs)
    Table 53. World Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Type (2024-2029) & (USD/Pcs)
    Table 54. World Gastrointestinal Stromal Tumor (GIST) Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Gastrointestinal Stromal Tumor (GIST) Drug Production by Application (2018-2023) & (K Pcs)
    Table 56. World Gastrointestinal Stromal Tumor (GIST) Drug Production by Application (2024-2029) & (K Pcs)
    Table 57. World Gastrointestinal Stromal Tumor (GIST) Drug Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Gastrointestinal Stromal Tumor (GIST) Drug Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Application (2018-2023) & (USD/Pcs)
    Table 60. World Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Application (2024-2029) & (USD/Pcs)
    Table 61. Ariad Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
    Table 62. Ariad Pharmaceuticals, Inc. Major Business
    Table 63. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 64. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Ariad Pharmaceuticals, Inc. Recent Developments/Updates
    Table 66. Ariad Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
    Table 67. Arog Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
    Table 68. Arog Pharmaceuticals, Inc. Major Business
    Table 69. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 70. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Arog Pharmaceuticals, Inc. Recent Developments/Updates
    Table 72. Arog Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
    Table 73. Array BioPharma Inc. Basic Information, Manufacturing Base and Competitors
    Table 74. Array BioPharma Inc. Major Business
    Table 75. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 76. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Array BioPharma Inc. Recent Developments/Updates
    Table 78. Array BioPharma Inc. Competitive Strengths & Weaknesses
    Table 79. Astex Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
    Table 80. Astex Pharmaceuticals, Inc. Major Business
    Table 81. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 82. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Astex Pharmaceuticals, Inc. Recent Developments/Updates
    Table 84. Astex Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
    Table 85. Blueprint Medicines Corporation Basic Information, Manufacturing Base and Competitors
    Table 86. Blueprint Medicines Corporation Major Business
    Table 87. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 88. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Blueprint Medicines Corporation Recent Developments/Updates
    Table 90. Blueprint Medicines Corporation Competitive Strengths & Weaknesses
    Table 91. Boston Biomedical, Inc. Basic Information, Manufacturing Base and Competitors
    Table 92. Boston Biomedical, Inc. Major Business
    Table 93. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 94. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Boston Biomedical, Inc. Recent Developments/Updates
    Table 96. Boston Biomedical, Inc. Competitive Strengths & Weaknesses
    Table 97. Calithera Biosciences, Inc. Basic Information, Manufacturing Base and Competitors
    Table 98. Calithera Biosciences, Inc. Major Business
    Table 99. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 100. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Calithera Biosciences, Inc. Recent Developments/Updates
    Table 102. Calithera Biosciences, Inc. Competitive Strengths & Weaknesses
    Table 103. Chipscreen Biosciences Ltd Basic Information, Manufacturing Base and Competitors
    Table 104. Chipscreen Biosciences Ltd Major Business
    Table 105. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 106. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Chipscreen Biosciences Ltd Recent Developments/Updates
    Table 108. Chipscreen Biosciences Ltd Competitive Strengths & Weaknesses
    Table 109. Deciphera Pharmaceuticals, LLC Basic Information, Manufacturing Base and Competitors
    Table 110. Deciphera Pharmaceuticals, LLC Major Business
    Table 111. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 112. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Deciphera Pharmaceuticals, LLC Recent Developments/Updates
    Table 114. Deciphera Pharmaceuticals, LLC Competitive Strengths & Weaknesses
    Table 115. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
    Table 116. F. Hoffmann-La Roche Ltd. Major Business
    Table 117. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 118. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
    Table 120. F. Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
    Table 121. Horizon Pharma Plc Basic Information, Manufacturing Base and Competitors
    Table 122. Horizon Pharma Plc Major Business
    Table 123. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 124. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Horizon Pharma Plc Recent Developments/Updates
    Table 126. Horizon Pharma Plc Competitive Strengths & Weaknesses
    Table 127. Immunicum AB Basic Information, Manufacturing Base and Competitors
    Table 128. Immunicum AB Major Business
    Table 129. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 130. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Immunicum AB Recent Developments/Updates
    Table 132. Immunicum AB Competitive Strengths & Weaknesses
    Table 133. Jiangsu Hengrui Medicine Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 134. Jiangsu Hengrui Medicine Co., Ltd. Major Business
    Table 135. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 136. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. Jiangsu Hengrui Medicine Co., Ltd. Recent Developments/Updates
    Table 138. Jiangsu Hengrui Medicine Co., Ltd. Competitive Strengths & Weaknesses
    Table 139. Kolltan Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
    Table 140. Kolltan Pharmaceuticals, Inc. Major Business
    Table 141. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 142. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 143. Kolltan Pharmaceuticals, Inc. Recent Developments/Updates
    Table 144. Kolltan Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
    Table 145. Natco Pharma Limited Basic Information, Manufacturing Base and Competitors
    Table 146. Natco Pharma Limited Major Business
    Table 147. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 148. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 149. Natco Pharma Limited Recent Developments/Updates
    Table 150. Natco Pharma Limited Competitive Strengths & Weaknesses
    Table 151. Nerviano Medical Sciences S.r.l. Basic Information, Manufacturing Base and Competitors
    Table 152. Nerviano Medical Sciences S.r.l. Major Business
    Table 153. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 154. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 155. Nerviano Medical Sciences S.r.l. Recent Developments/Updates
    Table 156. Nerviano Medical Sciences S.r.l. Competitive Strengths & Weaknesses
    Table 157. Novartis AG Basic Information, Manufacturing Base and Competitors
    Table 158. Novartis AG Major Business
    Table 159. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 160. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 161. Novartis AG Recent Developments/Updates
    Table 162. Omeros Corporation Basic Information, Manufacturing Base and Competitors
    Table 163. Omeros Corporation Major Business
    Table 164. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 165. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 166. Global Key Players of Gastrointestinal Stromal Tumor (GIST) Drug Upstream (Raw Materials)
    Table 167. Gastrointestinal Stromal Tumor (GIST) Drug Typical Customers
    Table 168. Gastrointestinal Stromal Tumor (GIST) Drug Typical Distributors
List of Figure
    Figure 1. Gastrointestinal Stromal Tumor (GIST) Drug Picture
    Figure 2. World Gastrointestinal Stromal Tumor (GIST) Drug Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Gastrointestinal Stromal Tumor (GIST) Drug Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Gastrointestinal Stromal Tumor (GIST) Drug Production (2018-2029) & (K Pcs)
    Figure 5. World Gastrointestinal Stromal Tumor (GIST) Drug Average Price (2018-2029) & (USD/Pcs)
    Figure 6. World Gastrointestinal Stromal Tumor (GIST) Drug Production Value Market Share by Region (2018-2029)
    Figure 7. World Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Region (2018-2029)
    Figure 8. North America Gastrointestinal Stromal Tumor (GIST) Drug Production (2018-2029) & (K Pcs)
    Figure 9. Europe Gastrointestinal Stromal Tumor (GIST) Drug Production (2018-2029) & (K Pcs)
    Figure 10. China Gastrointestinal Stromal Tumor (GIST) Drug Production (2018-2029) & (K Pcs)
    Figure 11. Japan Gastrointestinal Stromal Tumor (GIST) Drug Production (2018-2029) & (K Pcs)
    Figure 12. Gastrointestinal Stromal Tumor (GIST) Drug Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2018-2029) & (K Pcs)
    Figure 15. World Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Region (2018-2029)
    Figure 16. United States Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2018-2029) & (K Pcs)
    Figure 17. China Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2018-2029) & (K Pcs)
    Figure 18. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2018-2029) & (K Pcs)
    Figure 19. Japan Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2018-2029) & (K Pcs)
    Figure 20. South Korea Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2018-2029) & (K Pcs)
    Figure 21. ASEAN Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2018-2029) & (K Pcs)
    Figure 22. India Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2018-2029) & (K Pcs)
    Figure 23. Producer Shipments of Gastrointestinal Stromal Tumor (GIST) Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Gastrointestinal Stromal Tumor (GIST) Drug Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Gastrointestinal Stromal Tumor (GIST) Drug Markets in 2022
    Figure 26. United States VS China: Gastrointestinal Stromal Tumor (GIST) Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share 2022
    Figure 30. China Based Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share 2022
    Figure 32. World Gastrointestinal Stromal Tumor (GIST) Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Gastrointestinal Stromal Tumor (GIST) Drug Production Value Market Share by Type in 2022
    Figure 34. Amcasertib
    Figure 35. Anagrelide hydrochloride CR
    Figure 36. APG-1351
    Figure 37. Binimetinib
    Figure 38. Others
    Figure 39. World Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Type (2018-2029)
    Figure 40. World Gastrointestinal Stromal Tumor (GIST) Drug Production Value Market Share by Type (2018-2029)
    Figure 41. World Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Type (2018-2029) & (USD/Pcs)
    Figure 42. World Gastrointestinal Stromal Tumor (GIST) Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 43. World Gastrointestinal Stromal Tumor (GIST) Drug Production Value Market Share by Application in 2022
    Figure 44. Clinic
    Figure 45. Hospital
    Figure 46. Others
    Figure 47. World Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Application (2018-2029)
    Figure 48. World Gastrointestinal Stromal Tumor (GIST) Drug Production Value Market Share by Application (2018-2029)
    Figure 49. World Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Application (2018-2029) & (USD/Pcs)
    Figure 50. Gastrointestinal Stromal Tumor (GIST) Drug Industry Chain
    Figure 51. Gastrointestinal Stromal Tumor (GIST) Drug Procurement Model
    Figure 52. Gastrointestinal Stromal Tumor (GIST) Drug Sales Model
    Figure 53. Gastrointestinal Stromal Tumor (GIST) Drug Sales Channels, Direct Sales, and Distribution
    Figure 54. Methodology
    Figure 55. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Gastrointestinal Stromal Tumor (GIST) Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Gastrointestinal Stromal Tumor (GIST) Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 16 Jan 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Gastrointestinal Stromal Tumor (GIST) Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Gastrointestinal Stromal Tumor (GIST) Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Gastrointestinal Stromal Tumor (GIST) Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Gastrointestinal Stromal Tumor (GIST) Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Gastrointestinal Stromal Tumor (GIST) Drug

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>